These results suggest that fisetin inhibits the nuclear translocation of the transcription factor NF-κB and reduces its binding amounts on the promoter of uPA, thereby repressing the transcription of uPA through p38 MAPK signaling pathway in cervical cancer cells. Here, NFKB1 is linked to cervical carcinoma.